2018-03-15| Technology

Stephen Hawking, Legendary Physicist and Cosmologist, Dies at 76

by GeneOnline
Share To

The legendary scientist, Stephen William Hawking (January 8, 1942 – March 14, 2018) has passed away at the age of 76 at his home town in Cambridge, England, on March 14, 2018.

By Joanne Shih

Stephen Hawking, an English theoretical physicist, cosmologist, and the author of A Brief History of Time and many other popular publications, spent his life time exploring the mysteries of the cosmos, time and black holes.

In 1963, Hawking was diagnosed with a rare early-onset slow-progressing form of motor neurone disease, amyotrophic lateral sclerosis (ALS), when he was 21. The disease caused Hawking loss of physical abilities and gradually paralyzed him over the years, doctors gave him a life expectancy of two years at that time. Nevertheless, Hawking was not discouraged by his physical disabilities, but carries on an extraordinarily meaningful life with his passion for science. With physical accessibility devices, Hawking was able to communicate with others and deliver significant scientific works.

Hawking was the pioneer in studying the universes and the first to establish a theory of cosmology described the theory of relativity and quantum mechanics. Hawking also had a renowned collaboration with Roger Penrose on gravitational singularity theorems explaining that black holes emit radiation, which often called Hawking radiation.

His scientific works were recognized by the Fellow of the Royal Society of Arts (FRSA), and the Pontifical Academy of Sciences. In 2009, Hawking also received the Presidential Medal of Freedom, the highest civilian award in the United States.



© All rights reserved. Collaborate with us:
Related Post
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
Ways to Reduce Carbon Emission in Cement Manufacturing
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
Scroll to Top